Davis Polk Advises Temasek on Its Investment in TutorGroup Holding

Davis Polk advised Temasek in connection with its affiliate’s investment in Series B preferred shares of TutorGroup Holding. Affiliates of Alibaba Group, the China-based e-commerce company, and Qiming Venture Partners, a China-based venture capital fund, also participated in this round of financing. The aggregate investment size for this Series B round was close to $100 million. More >>

Tags:  Davis Polk & Wardwell LLP

Shearman & Sterling Represents Underwriters in Connection with HSBC Holdings plc’s US$3.5 Billion Notes Offering

Shearman & Sterling represented the underwriters (led by HSBC Securities (USA) Inc.) in connection with HSBC Holdings plc’s offering of US$2 billion aggregate principal amount of 4.250% subordinated notes due 2024 and US$1.5 billion aggregate principal amount of 5.250% subordinated notes due 2044. The subordinated notes qualify as Tier 2 capital under Basel III and are subject to the exercise of “bail-in” powers by UK regulatory authorities.

More >>

Tags:  Shearman & Sterling LLP

Mayer Brown successfully defends $22.8 billion contract award to Consolidated Nuclear Security

Mayer Brown’s Government Contracts group successfully represented Consolidated Nuclear Security LLC (CNS) in securing the award of a $22.8 billion contract by the National Nuclear Security Administration (NNSA) in the face of three protests by a competitor. The contract is believed to be the largest ever awarded by the US Department of Energy and the NNSA.

More >>

Tags:  Mayer Brown LLP

Simpson Thacher Represents JLL Partners and Patheon in $2 Billion Financing for Combination of Patheon and the Pharmaceutical Products Business of Royal DSM

The Firm represented JLL Partners, Inc. and its 56%-owned portfolio company, Patheon Inc., in the financing transactions for JLL Partners’ take-private acquisition of Patheon and Patheon’s related combination with the Pharmaceutical Products business of Koninklijke DSM N.V., known as Royal DSM. As a result of the transactions, which closed on March 11, 2014, the combined business is held by JLL/Delta Dutch Newco B.V. (the “Company”), which is 51% owned by JLL Partners and 49% owned by Royal DSM.

More >>

Tags:  Simpson Thacher & Bartlett LLP

Firm Advises on Synageva Biopharma’s $211.5 Million Equity Offering

On March 5, Synageva BioPharma Corp. announced the pricing of its previously announced underwritten public offering of common stock consisting of 2 million shares at $105.75 per share. Willkie represented book-running managers Goldman, Sachs & Co., J.P. Morgan Securities LLC, and Morgan Stanley & Co. LLC, in the offering. In connection with this offering, Synageva granted to the underwriters a 30-day option to purchase 300,000 additional shares of common stock. Massachusetts-based Synageva is a clinical stage biopharmaceutical company developing therapeutic products for life-threatening rare diseases. Willkie previously advised on Synageva’s $113 million and $90 million stock offerings in 2013 and 2012, respectively.

More >>

Leading Oil and Gas Attorney Michael Byrd Joins Akin Gump in Houston

Akin Gump today announced the addition of Michael J. Byrd as a partner in the firm’s energy practice in Houston. Mr. Byrd is an experienced and recognized attorney in the oil and gas industry, whose practice emphasizes upstream M&A transactions. He comes to Akin Gump from Baker & McKenzie, where he served as chair of that firm’s North America oil and gas practice group.

More >>

Tags:  Akin Gump Strauss Hauer & Feld LLP | Houston

Simpson Thacher Represents HCA in $3.5 Billion High Yield Debt Offering and Revolving Credit Facilities Refinancing

Simpson Thacher recently represented HCA Inc. in its high yield offering of $1.5 billion aggregate principal amount of 3.75% Senior Secured Notes due 2019 and $2.0 billion aggregate principal amount of 5.00% Senior Secured Notes due 2024. HCA intends to use the net proceeds for the repayment and redemption of certain series of its existing secured and unsecured notes and for general corporate purposes.

More >>

Tags:  Simpson Thacher & Bartlett LLP